Oral candidiasis
Basic details
Preferred term: Oral candidiasis
Alt. terms: oral thrush | candidiasis, oral | chronic oral thrush
HPO term: Chronic oral candidiasis
HPO code: HP:0009098
GenIA ID: 702
Last updated on: 2021-12-06 09:20:57
Cross ref. with other ontologies
NCIT: C28137
MESH: D002180
EFO:0007406
OAE:0001243
SNOMEDCT: -
ICD10: -
Description
Infection of the mucous membranes of the mouth by a fungus of the genus Candida, generally C. albicans. It is usually seen in infants, the elderly, and groups of people with weakened immune systems. It is characterized by a whitish growth and ulcers.
Hierarchical classification
Reported patients added to GenIA DB
SubjectID | Sex | Fam.ID | Age* | Population | MatchedTerm | Diagnosis | Reference & Pub.codes |
---|---|---|---|---|---|---|---|
101036 | F | 210182![]() |
- | Caucasian | Oral candidiasis | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:25329329 [Fam.B:II.2(B.II.1)]; PMID:29729943 [Fam.B:II.2(B.II.1 (13))]; PMID:34975878 [Fam.F014:III.2(P014)]; PMID:27418640 [P12(5)]; PMID:37740092 [P01] |
101063 | M | 210118 | -,- | German | Mucocutaneous candidiasis,Oral candidiasis | PMID:34975878 [Fam.F411:P411]; PMID:34390440 [CMC01] | |
101079 | M | 211310 | - | Mucocutaneous candidiasis | PMID:34975878 [Fam.F045:P045]; PMID:34390440 [NEG005] | ||
101129 | F | 210906 | 33 | German | Mucocutaneous candidiasis | PMID:34975878 [Fam.F078:P078] | |
101131 | F | 210337 | 54 | German | Oral candidiasis | PMID:34975878 [Fam.F080:P080] | |
101168 | M | 212349 | - | Oral candidiasis | PMID:34390440 [NEG015] | ||
101375 | F | 212162 | 13 | Iranian | Mucocutaneous candidiasis | Immunodeficiency, common variable, 8 | PMID:29461210 [Fam.1:II.1(P1)]; PMID:29528757 [Case 3]; PMID:26707784 [Fam.F:IV.1(P30)]; PMID:25011360 [Case 2]; PMID:26993986 [Fam.F7:II.1(1)]; PMID:28512785 [P8] |
101401 | F | 210205![]() |
- | Caucasian | Mucocutaneous candidiasis | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:25329329 [Fam.A:II.17(A.II.9)]; PMID:29729943 [Fam.A:II.17(A.II.9 (6))]; PMID:27418640 [P9(5)] |
101473 | F | 212398 | 1 | Spanish | Oral candidiasis | Immunodeficiency, common variable, 8 | PMID:30386343 [Patient(II.1)] |
101576 | M | 212599 | - | Oral candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:34390440 [HIES47] | |
101578 | M | 210205![]() |
- | German | Mucocutaneous candidiasis | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:25329329 [Fam.A:II.14(A.II.8)]; PMID:29729943 [Fam.A:II.14(A.II.8 (5))]; PMID:27418640 [P8(5)] |
101687 | F | 212635![]() |
- | Nepalese | Oral candidiasis | ARPC1B deficiency | PMID:30771411 [P12(II.1)] |
101792 | M | 210991 | - | Caucasian | Mucocutaneous candidiasis | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.NN:II.11(NN.II.9(92))] |
101797 | M | 211108 | -,- | Caucasian | Mucocutaneous candidiasis,Oral candidiasis | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.QQ:II.1(97)]; PMID:34975878 [Fam.F258:P258] |
101821 | F | 210122 | - | Mucocutaneous candidiasis | PMID:34390440 [NEG027] | ||
101831 | M | 210126 | - | Israeli | Oral candidiasis | Immunodeficiency 31C | PMID:34390440 [CMC18] |
101844 | F | 210124 | - | Mucocutaneous candidiasis | PMID:34390440 [NEG030] | ||
101845 | M | 210125 | - | German | Mucocutaneous candidiasis | PMID:34390440 [NEG031] | |
101858 | U | 210051 | - | Mucocutaneous candidiasis | Immunodeficiency 31C | PMID:34390440 [CMC14] | |
101859 | U | 210052 | - | Mucocutaneous candidiasis | Immunodeficiency 31C | PMID:34390440 [CMC15] | |
101861 | U | 210054 | - | Mucocutaneous candidiasis | Immunodeficiency 31C | PMID:34390440 [CMC17] | |
101862 | F | 210064 | -,- | Mucocutaneous candidiasis,Oral candidiasis | PMID:34390440 [NEG035] | ||
101863 | M | 210066 | -,- | Mucocutaneous candidiasis,Oral candidiasis | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:34390440 [NEG036] | |
101865 | F | 210068 | - | Mucocutaneous candidiasis | PMID:34390440 [NEG038] | ||
101867 | M | 210072 | - | Mucocutaneous candidiasis | PMID:34390440 [NEG040] | ||
101868 | M | 210073 | - | Mucocutaneous candidiasis | PMID:34390440 [NEG041] | ||
101869 | M | 210076 | - | Oral candidiasis | Immunodeficiency 31C | PMID:34390440 [CMC08] | |
101871 | F | 210078 | - | Turkish | Mucocutaneous candidiasis | Immunodeficiency 103, susceptibility to fungal infection | PMID:34390440 [CMC03] |
101872 | M | 210081 | -,- | German | Mucocutaneous candidiasis,Oral candidiasis | PMID:34390440 [NEG043] | |
101873 | F | 210082 | - | Mucocutaneous candidiasis | PMID:34390440 [NEG044] | ||
101875 | F | 210086 | - | Mucocutaneous candidiasis | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:34390440 [CMC19] | |
101876 | M | 210088 | - | Turkish | Mucocutaneous candidiasis | Immunodeficiency 103, susceptibility to fungal infection | PMID:34390440 [CMC02] |
101884 | M | 212237![]() |
- | Sudanese | Oral candidiasis | Hyper-IgE recurrent infection syndrome 3 | PMID:29907690 [Fam.A:III.3(A.II.3)] |
101899 | M | 211769 | - | Mucocutaneous candidiasis | PMID:34975878 [Fam.F329:P329] | ||
101907 | F | 212325 | - | Oral candidiasis | PMID:34390440 [NEG056] | ||
101916 | F | 210075 | - | Oral candidiasis | PMID:34390440 [NEG058] | ||
101917 | F | 210079 | - | Oral candidiasis | PMID:34390440 [NEG059] | ||
101920 | M | 210089 | - | Turkish | Oral candidiasis | IL-17RA deficiency | PMID:34390440 [CMC06] |
101921 | M | 210091 | - | Turkish | Mucocutaneous candidiasis | Immunodeficiency 103, susceptibility to fungal infection | PMID:34390440 [CMC04] |
101923 | F | 210092 | - | Mucocutaneous candidiasis | PMID:34390440 [NEG061] | ||
101924 | M | 210094 | - | German | Oral candidiasis | Immunodeficiency 31C | PMID:34390440 [CMC05] |
101930 | M | 210100 | -,1 | Algerian | Mucocutaneous candidiasis,Oral candidiasis | Immunodeficiency 31C | PMID:34390440 [CMC13] |
101933 | M | 210103 | - | Mucocutaneous candidiasis | PMID:34390440 [NEG066] | ||
101939 | M | 210109 | - | Mucocutaneous candidiasis | PMID:34390440 [NEG072] | ||
101943 | F | 210113 | - | Mucocutaneous candidiasis | PMID:34390440 [NEG075] | ||
101958 | F | 212666 | - | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:34390440 [HIES40] | |
101962 | M | 212237![]() |
-,- | Sudanese | Mucocutaneous candidiasis,Oral candidiasis | Hyper-IgE recurrent infection syndrome 3 | PMID:29907690 [Fam.A:III.2(A.II.2)] |
101970 | F | 214044 | - | Oral candidiasis | PMID:34390440 [NEG085] | ||
101975 | F | 214053![]() |
- | Turkish | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 3 | PMID:29907690 [Fam.D:IV.2(D.II.1)]; PMID:34390440 [HIES53]; PMID:31980991 [Case] |
101980 | F | 214063 | - | Oral candidiasis | PMID:34390440 [NEG088] | ||
101984 | F | 214091 | - | Oral candidiasis | PMID:34390440 [NEG091] | ||
101988 | M | 214120 | - | Oral candidiasis | PMID:34390440 [NEG095] | ||
101989 | F | 214121 | - | Oral candidiasis | PMID:34390440 [NEG096] | ||
101990 | F | 214122 | - | Oral candidiasis | PMID:34390440 [NEG097] | ||
101991 | M | 214123 | - | Turkish | Mucocutaneous candidiasis | Immunodeficiency 103, susceptibility to fungal infection | PMID:34390440 [HIES03] |
102006 | F | 214161 | - | Oral candidiasis | PMID:34390440 [NEG109] | ||
102014 | F | 214191 | - | Oral candidiasis | PMID:34390440 [NEG116] | ||
102033 | M | 214226 | - | Oral candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:34390440 [HIES33] | |
102035 | M | 214232 | - | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:34390440 [HIES34] | |
102058 | M | 214276 | -,- | Iranian | Mucocutaneous candidiasis,Oral candidiasis | Immunodeficiency 103, susceptibility to fungal infection | PMID:34390440 [HIES04] |
102074 | F | 214294 | - | Egyptian | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 2 | PMID:34390440 [HIES27]; PMID:32738296 [P2] |
102082 | U | 214302 | - | Egyptian | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 2 | PMID:34390440 [HIES11] |
102111 | F | 214335 | - | Mucocutaneous candidiasis | PMID:34390440 [NEG190] | ||
102124 | F | 214351![]() |
- | Sudanese | Oral candidiasis | Hyper-IgE recurrent infection syndrome 3 | PMID:29907690 [Fam.B:IV.5(B.II.4)] |
102129 | F | 214351![]() |
- | Sudanese | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 3 | PMID:29907690 [Fam.B:IV.1(B.II.1)] |
102131 | F | 214351![]() |
- | Sudanese | Oral candidiasis | Hyper-IgE recurrent infection syndrome 3 | PMID:29907690 [Fam.B:IV.7(B.II.6)] |
102181 | F | 214913 | 3 | Mucocutaneous candidiasis | Severe combined immunodeficiency 9A, T-B- | PMID:30877075 [Case 22]; PMID:28864286 [P1]; PMID:28769923 [P34] | |
102222 | M | 214917 | 52 | German | Mucocutaneous candidiasis | NFKB1 insufficiency | PMID:32278790 [BY.I.1]; PMID:35486341 [P074]; PMID:150198 [Fam.DJ:467]; PMID:36105815 [W295C] |
102258 | M | 214926![]() |
0 | Mexican | Oral candidiasis | ARPC1B deficiency | PMID:32683750 [case(II.3)]; PMID:36708766 [Fam.A:II.3(P2)] |
102262 | F | 214927![]() |
1 | Japanese | Oral candidiasis | OAS1 immunodeficiency | PMID:29455859 [Fam.C:II.1]; PMID:34145065 [P5(II.1)]; PMID:29185156 [P2] |
102654 | F | 214978![]() |
1 | North American | Oral candidiasis | Immunodeficiency 8 | PMID:19097825 [Patient(II.2)]; PMID:18836449 [Patient(II.2)] |
102769 | M | 214985![]() |
-,- | Moroccan | Mucocutaneous candidiasis,Oral candidiasis | Hyper-IgE recurrent infection syndrome 3 | PMID:29907691 [Fam.A:II.2(P2)] |
102772 | M | 214985![]() |
- | Moroccan | Mucocutaneous candidiasis | PMID:29907691 [Fam.A:II.1(P1)] | |
102774 | F | 214985![]() |
-,- | Moroccan | Mucocutaneous candidiasis,Oral candidiasis | Hyper-IgE recurrent infection syndrome 3 | PMID:29907691 [Fam.A:II.4(P3)] |
102775 | F | 214986![]() |
-,- | Afro-Caribbean | Mucocutaneous candidiasis,Oral candidiasis | Hyper-IgE recurrent infection syndrome 3 | PMID:29907691 [Fam.B:II.5(P4)] |
102782 | F | 214987![]() |
-,- | Iranian | Mucocutaneous candidiasis,Oral candidiasis | Hyper-IgE recurrent infection syndrome 3 | PMID:29907691 [Fam.C:II.2(P5)] |
102792 | M | 214989![]() |
-,- | Turkish | Mucocutaneous candidiasis,Oral candidiasis | Hyper-IgE recurrent infection syndrome 3 | PMID:29907691 [Fam.E:II.1(P7)] |
102891 | F | 215006![]() |
- | Indian | Oral candidiasis | T-cell immunodeficiency, congenital alopecia, and nail dystrophy | PMID:28636882 [Patient(II.3)]; PMID:33464451 [P6] |
102894 | M | 215006![]() |
- | Indian | Oral candidiasis | T-cell immunodeficiency, congenital alopecia, and nail dystrophy | PMID:28636882 [Fam.Patient:II.2]; PMID:33464451 [P7] |
102897 | M | 215007![]() |
- | Turkish | Oral candidiasis | T-cell immunodeficiency, congenital alopecia, and nail dystrophy | PMID:30903456 [P1(II.1)]; PMID:33464451 [P12(II.1)]; PMID:37419334 [P12(27)] |
102900 | F | 215007![]() |
- | Turkish | Oral candidiasis | T-cell immunodeficiency, congenital alopecia, and nail dystrophy | PMID:30903456 [Fam.P1:II.2(P2)]; PMID:33464451 [Fam.P12:II.2(P13)]; PMID:37419334 [P13(27)] |
102934 | F | 215035![]() |
- | Caucasian | Mucocutaneous candidiasis | T-cell lymphopenia with or without nail dystrophy, AD | PMID:31447097 [P23]; PMID:33464451 [P14(III.1)]; PMID:37419334 [P23(22)] |
102948 | F | 215047 | - | Italian | Mucocutaneous candidiasis | T-cell lymphopenia with or without nail dystrophy, AD | PMID:31447097 [P39]; PMID:37419334 [P39(22)] |
102993 | F | 215077![]() |
- | Turkish | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:17676033 [Patient 2] |
102996 | M | 215078![]() |
- | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:17676033 [Patient 3] | |
103002 | F | 215080![]() |
- | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:17676033 [Patient 5] | |
103012 | M | 215083![]() |
- | Turkish | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:17676033 [Patient 7] |
103015 | M | 215084![]() |
- | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:17676033 [Patient 8] | |
103018 | M | 215085![]() |
- | Japanese | Oral candidiasis | Immunodeficiency 35 | PMID:17676033 [Tyk2 Pt]; PMID:17088085 [Patient] |
103031 | M | 215088 | - | Hungarian | Oral candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20159255 [UPN134]; PMID:18706697 [Fam.3:K] |
103032 | M | 215089![]() |
- | Hungarian | Oral candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:18706697 [Fam.4:II.1(S1)] |
103043 | F | 215093 | - | Polish | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:18706697 [Fam.8:B] |
103051 | M | 215095![]() |
- | Finnish | Oral candidiasis | Seizures, cortical blindness, microcephaly syndrome | PMID:33662367 [Fam.F1:II.7(P1)] |
103567 | F | 215161![]() |
- | Caucasian | Oral candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:17881745 [Fam.J007:III.1(Daughter)]; PMID:28587312 [P40]; PMID:21288777 [Fam.3:III.1(Daughter)] |
103584 | F | 215166![]() |
- | Caucasian | Oral candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:17881745 [Fam.J011:II.2(Proband)]; PMID:21288777 [Fam.4:II.2(Proband)] |
103587 | F | 215166![]() |
- | Caucasian | Oral candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:17881745 [Fam.J011:II.1(Sister)]; PMID:21288777 [Fam.4:II.1(sister)] |
103591 | F | 215168![]() |
- | Caucasian | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:17881745 [Fam.J014:II.1(Proband)]; PMID:28587312 [P34] |
103604 | M | 215170![]() |
- | Asian | Oral candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:17881745 [Fam.J016:II.2(Proband)]; PMID:21288777 [Fam.5:II.1(Proband)] |
103607 | F | 215171![]() |
- | Caucasian | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:17881745 [Fam.J017:II.1(Proband)]; PMID:21288777 [Fam.6:II.1(Proband)] |
103612 | M | 215171![]() |
- | Caucasian | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:17881745 [Fam.J017:II.4(Brother2)]; PMID:28587312 [P32]; PMID:21288777 [Fam.6:II.4(brother)] |
103619 | F | 215174 | - | North American | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:17881745 [Fam.J022:Proband]; PMID:28587312 [P9]; PMID:23584561 [T2-1] |
103626 | F | 215175![]() |
- | Caucasian | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:17881745 [Fam.J029:II.2(Sister2)]; PMID:21288777 [Fam.7:II.2(sister2)] |
103629 | F | 215175![]() |
- | Caucasian | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:17881745 [Fam.J029:III.2(Niece2)]; PMID:21288777 [Fam.7:III.2(niece)] |
103633 | F | 215177![]() |
- | Caucasian | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:17881745 [Fam.J035:II.1(Daughter)]; PMID:21288777 [Fam.12:II.1(daughter)] |
103635 | M | 215177![]() |
- | Caucasian | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:17881745 [Fam.J035:I.2(Proband)]; PMID:21288777 [Fam.12:I.1(proband)] |
103647 | F | 215182![]() |
- | Caucasian | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:17881745 [Fam.J074:II.1(Daughter)]; PMID:21288777 [Fam.8:II.1(proband)] |
103648 | F | 215182![]() |
- | Caucasian | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:17881745 [Fam.J074:I.1(Proband)]; PMID:21288777 [Fam.8:I.2(mother)]; PMID:23584561 [T3-1] |
103650 | F | 215182![]() |
- | Caucasian | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:17881745 [Fam.J074:II.2(Daughter2)]; PMID:21288777 [Fam.8:II.2(sister)] |
103655 | F | 215184![]() |
- | Caucasian | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:17881745 [Fam.J087:II.1(Daughter)]; PMID:21288777 [Fam.9:II.1(Daughter)] |
103656 | M | 215184![]() |
- | Caucasian | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:17881745 [Fam.J087:I.1(Proband)]; PMID:21288777 [Fam.9:I.1(proband)] |
103663 | F | 215187![]() |
- | Latino | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:17881745 [Fam.J100:Proband]; PMID:28587312 [P41]; PMID:21288777 [Fam.10:I.2(proband)]; PMID:23584561 [T3-11] |
103667 | M | 215188![]() |
- | Caucasian | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:17881745 [Fam.J112:I.1(Proband)]; PMID:21288777 [Fam.11:I.1(proband)]; PMID:23584561 [T3-7] |
103668 | M | 215189![]() |
- | Caucasian | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:17881745 [Fam.J113:II.1(Proband)]; PMID:28587312 [P53]; PMID:23584561 [T2-13] |
103676 | F | 215193 | - | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:18602572 [P2] | |
103677 | M | 215194 | - | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:18602572 [P3] | |
103678 | M | 215195 | - | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:18602572 [P4] | |
103679 | M | 215196![]() |
- | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:18602572 [P5] | |
103680 | M | 215197 | - | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:18602572 [P6] | |
103681 | F | 215198![]() |
- | North American | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:18602572 [Fam.7:II.3(P7.1)]; PMID:17942886 [II-3(II.3)] |
103682 | M | 215198![]() |
- | North American | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:18602572 [Fam.7:III.3(P7.2)]; PMID:17942886 [Fam.II-3:III.3(III-3)] |
103684 | M | 215201![]() |
- | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:18602572 [P8] | |
103685 | M | 215202![]() |
- | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:18602572 [P9] | |
103686 | M | 215203![]() |
- | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:18602572 [P10] | |
103687 | M | 215204![]() |
- | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:18602572 [P11] | |
103688 | M | 215205 | - | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:18602572 [P12] | |
103689 | M | 215206 | - | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:18602572 [P13] | |
103690 | M | 215207 | - | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:18602572 [P14] | |
103691 | M | 215208 | - | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:18602572 [P15] | |
103692 | M | 215209 | - | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:18602572 [P16] | |
103695 | M | 215212![]() |
- | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:18602572 [P19] | |
103696 | F | 215213![]() |
- | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:18602572 [P20] | |
103697 | M | 215214![]() |
- | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:18602572 [P21] | |
103698 | M | 215215![]() |
- | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:18602572 [P22] | |
103699 | M | 215216![]() |
- | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:18602572 [P23] | |
103700 | F | 215217 | - | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:18602572 [P24] | |
103702 | M | 215219 | - | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:18602572 [P26] | |
103706 | F | 215223 | - | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:18602572 [P30] | |
103707 | M | 215224![]() |
- | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:18602572 [P31] | |
103708 | M | 215225 | - | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:18602572 [P32] | |
103709 | M | 215226 | - | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:18602572 [P33] | |
103710 | F | 215227 | - | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:18602572 [P34] | |
103715 | M | 215228 | - | Caucasian | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:17881745 [Fam.J012:Proband]; PMID:28587312 [P25] |
103788 | M | 215242![]() |
- | South Korean | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:19348930 [Patient(II.1)] |
103792 | F | 215243![]() |
- | North American | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20093388 [Fam.1:III.3(1-2)] |
103798 | M | 215243![]() |
- | North American | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20093388 [Fam.1:II.4(1-1)] |
103802 | F | 215243![]() |
- | North American | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20093388 [Fam.1:III.4(1-3)] |
103803 | M | 215244 | - | North American | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20093388 [2-1] |
103804 | M | 215245![]() |
- | North American | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20093388 [Fam.3:II.10(3-1)] |
103805 | F | 215246 | - | North American | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20093388 [4-1] |
103806 | M | 215247 | - | North American | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20093388 [5-1] |
103807 | M | 215248![]() |
- | North American | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20093388 [Fam.6:III.1(6-2)] |
103808 | F | 215248![]() |
- | North American | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20093388 [Fam.6:II.3(6-1)] |
103810 | F | 215249![]() |
- | North American | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20093388 [Fam.7:III.4(7-3)] |
103811 | F | 215249![]() |
- | North American | Mucocutaneous candidiasis | PMID:20093388 [Fam.7:II.5] | |
103812 | M | 215249![]() |
- | North American | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20093388 [Fam.7:II.4(7-1)] |
103813 | F | 215249![]() |
- | North American | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20093388 [Fam.7:III.3(7-2)] |
103814 | M | 215250 | - | North American | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20093388 [8-1] |
103816 | F | 215252![]() |
- | North American | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20093388 [Fam.10:II.1(10-2)] |
103817 | F | 215252![]() |
- | North American | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20093388 [Fam.10:I.1(10-1)] |
103917 | F | 215272![]() |
- | French | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K3:II.2(P4)] |
103920 | M | 215272![]() |
- | French | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K3:II.1(P60)] |
103922 | F | 215274 | - | French | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K5:P6] |
103923 | M | 215275![]() |
- | French | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K6:II.1(P8)] |
103925 | F | 215275![]() |
- | French | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K6:I.2(P7)] |
103926 | F | 215276 | - | French | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K7:P9] |
103927 | F | 215277 | - | French | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K8:P10] |
103928 | M | 215278 | - | Algerian | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K9:P11] |
103929 | M | 215279 | - | French | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K10:P12] |
103930 | F | 215280 | - | Moroccan | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K11:P13] |
103931 | M | 215281![]() |
- | French | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K12:II.2(P16)] |
103933 | F | 215281![]() |
- | French | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K12:I.2(P14)] |
103935 | F | 215282 | - | French | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K13:P17] |
103937 | F | 215284 | - | French | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K15:P19] |
103938 | M | 215285 | - | French | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K16:P20] |
103940 | F | 215287![]() |
- | French | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K18:P22] |
103944 | M | 215287![]() |
- | French | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K18:II.2(P23)] |
103945 | M | 215289 | - | French | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K19:P24] |
103946 | F | 215290 | - | French | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K20:P25] |
103948 | F | 215292 | - | French | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K22:P27] |
103949 | M | 215293![]() |
- | French | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K23:II.2(P30)] |
103951 | M | 215293![]() |
- | French | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K23:I.2(P28)] |
103953 | F | 215294 | - | French | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K24:P31] |
103954 | M | 215295 | - | Algerian | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K25:P32] |
103956 | M | 215297 | - | French | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K27:P34] |
103958 | M | 215298![]() |
- | French | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K28:I.1(P35)] |
103961 | F | 215299 | - | French | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K29:P36] |
103962 | F | 215300![]() |
- | French | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K30:II.1(P38)] |
103963 | M | 215300![]() |
- | French | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K30:I.1(P37)] |
103965 | F | 215301 | - | French | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K31:P39] |
103966 | F | 215302 | - | French | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K32:P40] |
103967 | M | 215303 | - | French | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K33:P41] |
103971 | F | 215305![]() |
- | Pakistani | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K35:I.2(P43)] |
103972 | M | 215305![]() |
- | Pakistani | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K35:II.1(P44)] |
103973 | M | 215306 | - | French | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K36:P46] |
103974 | M | 215307 | - | French | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K37:P47] |
103977 | F | 215308![]() |
- | French | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K38:I.2(P48)] |
103978 | M | 215309 | - | French | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K39:P50] |
103979 | M | 215310 | - | French | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K40:P51] |
103980 | F | 215311 | - | French | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K41:P52] |
103981 | M | 215312 | - | French | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K42:P53] |
103982 | F | 215313 | - | French | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K43:P54] |
103983 | M | 215314 | - | French | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K44:P55] |
103985 | M | 215316 | - | Portuguese | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K46:P57] |
103986 | M | 215317 | - | French | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K47:P58] |
104001 | F | 215322![]() |
- | North American | Mucocutaneous candidiasis | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:25359994 [P5]; PMID:32392079 [P3]; PMID:30092289 [P15]; PMID:35677041 [Pt3]; PMID:33651637 [Patient 1] |
104052 | F | 215328![]() |
- | European | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20159255 [UPN110]; GRID:000796 [UPN110(II.1)] |
104054 | F | 215330 | -,- | European | Mucocutaneous candidiasis,Oral candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20159255 [UPN70]; PMID:18835223 [UPN70]; GRID:000796 [UPN70] |
104055 | F | 215331 | -,- | European | Mucocutaneous candidiasis,Oral candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20159255 [UPN7]; PMID:18835223 [UPN7]; GRID:000796 [UPN7] |
104056 | M | 215332 | -,- | European | Mucocutaneous candidiasis,Oral candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20159255 [UPN114]; GRID:000796 [UPN114] |
104057 | M | 215333 | -,- | European | Mucocutaneous candidiasis,Oral candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20159255 [UPN86]; GRID:000796 [UPN86] |
104058 | F | 215334 | - | European | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20159255 [UPN17]; PMID:18835223 [UPN17]; GRID:000796 [UPN17] |
104059 | M | 215335 | - | European | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20159255 [UPN108]; GRID:000796 [UPN108] |
104060 | M | 215336 | - | European | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20159255 [UPN15]; PMID:18835223 [UPN15]; GRID:000796 [UPN15] |
104061 | M | 215337![]() |
-,- | European | Mucocutaneous candidiasis,Oral candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20159255 [UPN19]; PMID:18835223 [UPN19]; GRID:000796 [UPN19(II.1)] |
104062 | F | 215338 | -,- | Colombian | Mucocutaneous candidiasis,Oral candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20159255 [UPN29]; PMID:18835223 [UPN29]; GRID:000796 [UPN29] |
104063 | M | 215339 | - | Colombian | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20159255 [UPN31]; PMID:18835223 [UPN31]; GRID:000796 [UPN31] |
104064 | M | 215340 | -,- | Middle Eastern | Mucocutaneous candidiasis,Oral candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20159255 [UPN43]; GRID:000796 [UPN43] |
104066 | M | 215342 | - | Middle Eastern | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20159255 [UPN63]; GRID:000796 [UPN63] |
104068 | F | 215344 | -,- | European | Mucocutaneous candidiasis,Oral candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20159255 [UPN126]; GRID:000796 [UPN126] |
104069 | F | 215345 | - | European | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20159255 [UPN128]; GRID:000796 [UPN128] |
104070 | M | 215346 | - | European | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20159255 [UPN129]; GRID:000796 [UPN129] |
104073 | M | 215349 | -,- | European | Mucocutaneous candidiasis,Oral candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20159255 [UPN135]; GRID:000796 [UPN135] |
104074 | F | 215350 | - | European | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20159255 [UPN79]; PMID:18835223 [UPN79]; GRID:000796 [UPN79] |
104075 | M | 215351 | -,- | European | Mucocutaneous candidiasis,Oral candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20159255 [UPN98]; GRID:000796 [UPN98] |
104076 | F | 215352 | - | European | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20159255 [UPN25]; GRID:000796 [UPN25] |
104080 | M | 215356 | - | Middle Eastern | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20159255 [UPN61]; GRID:000796 [UPN61] |
104081 | M | 215357 | - | Middle Eastern | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20159255 [UPN72]; GRID:000796 [UPN72] |
104082 | M | 215358 | - | Middle Eastern | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20159255 [UPN77]; GRID:000796 [UPN77] |
104086 | M | 215362![]() |
- | Middle Eastern | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20159255 [UPN60]; GRID:000796 [UPN60(I.1)] |
104087 | M | 215363![]() |
- | Middle Eastern | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20159255 [UPN65]; GRID:000796 [UPN65(II.2)] |
104090 | F | 215366 | -,- | European | Mucocutaneous candidiasis,Oral candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20159255 [UPN26]; GRID:000796 [UPN26] |
104091 | F | 215367![]() |
- | European | Oral candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20159255 [UPN2]; PMID:18835223 [UPN2]; GRID:000796 [UPN2(II.4)] |
104093 | M | 215369 | -,- | European | Mucocutaneous candidiasis,Oral candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20159255 [UPN102]; GRID:000796 [UPN102] |
104094 | M | 215370 | -,- | European | Mucocutaneous candidiasis,Oral candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20159255 [UPN36]; GRID:000796 [UPN36] |
104095 | F | 215371 | - | European | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20159255 [UPN57]; GRID:000796 [UPN57] |
104097 | M | 215373 | -,- | European | Mucocutaneous candidiasis,Oral candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20159255 [UPN71]; PMID:18835223 [UPN71]; GRID:000796 [UPN71] |
104098 | F | 215374 | -,- | European | Mucocutaneous candidiasis,Oral candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20159255 [UPN16]; PMID:18835223 [UPN16]; GRID:000796 [UPN16] |
104099 | M | 215375 | 13 | Colombian | Oral candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20159255 [UPN32]; PMID:18835223 [UPN32]; GRID:000796 [UPN32] |
104100 | M | 215376 | -,- | Colombian | Mucocutaneous candidiasis,Oral candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20159255 [UPN33]; PMID:18835223 [UPN33]; GRID:000796 [UPN33] |
104102 | M | 215378 | -,- | Middle Eastern | Mucocutaneous candidiasis,Oral candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20159255 [UPN45]; GRID:000796 [UPN45] |
104103 | F | 215379 | - | European | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20159255 [UPN66]; GRID:000796 [UPN66] |
104108 | M | 215384 | - | European | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20159255 [UPN104]; GRID:000796 [UPN104] |
104109 | M | 215385 | - | North American | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20159255 [UPN49]; GRID:000796 [UPN49] |
104110 | F | 215386 | - | European | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20159255 [UPN109]; GRID:000796 [UPN109] |
104111 | M | 215387 | -,- | Latino | Mucocutaneous candidiasis,Oral candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20159255 [UPN27]; GRID:000796 [UPN27] |
104112 | F | 215388 | -,- | European | Mucocutaneous candidiasis,Oral candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20159255 [UPN103]; GRID:000796 [UPN103] |
104113 | M | 215389 | -,- | European | Mucocutaneous candidiasis,Oral candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20159255 [UPN18]; PMID:18835223 [UPN18]; GRID:000796 [UPN18] |
104114 | M | 215390 | -,- | European | Mucocutaneous candidiasis,Oral candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20159255 [UPN116]; GRID:000796 [UPN116] |
104190 | F | 215399 | -,- | Latino | Mucocutaneous candidiasis,Oral candidiasis | Hyper-IgE recurrent infection syndrome 1 | GRID:000796 [UPN30] |
104191 | F | 215400 | - | Middle Eastern | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | GRID:000796 [UPN136] |
104193 | M | 215402 | - | European | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | GRID:000796 [UPN147] |
104194 | M | 215403 | -,- | European | Mucocutaneous candidiasis,Oral candidiasis | Hyper-IgE recurrent infection syndrome 1 | GRID:000796 [UPN151] |
104195 | M | 215404 | - | European | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | GRID:000796 [UPN152] |
104201 | F | 215408 | -,- | European | Mucocutaneous candidiasis,Oral candidiasis | Hyper-IgE recurrent infection syndrome 1 | GRID:000796 [UPN158] |
104202 | F | 215409 | - | European | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | GRID:000796 [UPN159] |
104248 | M | 215424 | - | Afro-American | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:28587312 [P10]; PMID:23584561 [T2-10] |
104250 | F | 215426 | - | North American | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:28587312 [P15] |
104251 | M | 215427 | - | North American | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:28587312 [P16]; PMID:35059947 [Patient 4] |
104255 | M | 215431 | - | Afro-American | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:28587312 [P20]; PMID:32768442 [Patient 5] |
104263 | F | 215439 | - | Afro-American | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:28587312 [P36]; PMID:23584561 [T2-17] |
104296 | M | 215449![]() |
- | Chinese (China) | Oral candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:21107604 [Case(II.1)] |
104300 | F | 215450![]() |
- | Greek | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:20149460 [Patient] |
104311 | M | 215452 | - | Australian | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:18591410 [HIES1] |
104313 | M | 215454 | - | Australian | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:18591410 [HIES3] |
104314 | F | 215455![]() |
- | Australian | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:18591410 [HIES4] |
104315 | F | 215456 | - | Australian | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:18591410 [HIES5] |
104336 | F | 215475 | - | Oral candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:21288777 [N472D]; PMID:23584561 [T2-9] | |
104349 | M | 215488 | - | Oral candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:21288777 [del371-380]; PMID:23584561 [T3-14] | |
104369 | F | 215508 | - | Oral candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:21288777 [V343F] | |
104385 | F | 215517![]() |
- | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:21288777 [Fam.13:I.2(mother)] | |
104438 | F | 215527![]() |
- | Middle Eastern | Mucocutaneous candidiasis | Early-onset atopic inflammation | PMID:36884218 [Fam.A:II.1(P1)] |
104449 | M | 215529![]() |
- | Middle Eastern | Oral candidiasis | Early-onset atopic inflammation | PMID:36884218 [Fam.C:II.1(P4)] |
104465 | M | 215533![]() |
- | Mucocutaneous candidiasis | Early-onset atopic inflammation | PMID:36884218 [Fam.G:II.1(P10)] | |
104847 | M | 215581 | 0 | Egyptian | Oral candidiasis | Omenn syndrome 2 | PMID:30307608 [2] |
104848 | F | 215582 | 0 | Egyptian | Oral candidiasis | Omenn syndrome 2 | PMID:30307608 [3] |
104856 | F | 215590 | 0 | Egyptian | Oral candidiasis | Severe combined immunodeficiency 9B, T-B- | PMID:30307608 [9] |
104858 | M | 215592 | 0 | Egyptian | Oral candidiasis | Severe combined immunodeficiency 9B, T-B- | PMID:30307608 [11] |
104859 | M | 215593 | 0 | Egyptian | Oral candidiasis | Severe combined immunodeficiency 9B, T-B- | PMID:30307608 [12] |
104862 | F | 215596 | 0 | Egyptian | Oral candidiasis | Severe combined immunodeficiency 9B, T-B- | PMID:30307608 [15] |
104866 | F | 215600 | 0 | Egyptian | Oral candidiasis | Severe combined immunodeficiency 9B, T-B- | PMID:30307608 [18] |
104867 | F | 215601 | 0 | Egyptian | Oral candidiasis | Severe combined immunodeficiency 9B, T-B- | PMID:30307608 [19] |
104871 | M | 215602 | 0 | Egyptian | Oral candidiasis | Severe combined immunodeficiency 9A, T-B- | PMID:30307608 [21] |
104879 | F | 215606 | - | Egyptian | Oral candidiasis | Severe combined immunodeficiency 9A, T-B- | PMID:30307608 [25] |
104880 | M | 215607 | - | Egyptian | Oral candidiasis | Severe combined immunodeficiency 9A, T-B- | PMID:30307608 [26] |
104881 | F | 215608 | - | Egyptian | Oral candidiasis | Severe combined immunodeficiency 10A, T-B+ | PMID:30307608 [27] |
104882 | F | 215609 | - | Egyptian | Oral candidiasis | Severe combined immunodeficiency 10B, T-B+ | PMID:30307608 [28] |
104884 | M | 215611 | - | Egyptian | Oral candidiasis | Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity | PMID:30307608 [30] |
104886 | F | 215613![]() |
- | Caucasian | Mucocutaneous candidiasis | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.G:III.1(G.III.1 (26))]; PMID:25367873 [Fam.1:III.6(III.6)] |
105019 | M | 215624![]() |
- | French | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:31346092 [P1(III.4)] |
105023 | M | 215624![]() |
- | French | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:31346092 [Fam.P1:II.2(P2)] |
105058 | F | 215624![]() |
- | French | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:31346092 [Fam.P1:II.3(P4)] |
105063 | F | 215624![]() |
- | French | Mucocutaneous candidiasis | Hyper-IgE recurrent infection syndrome 1 | PMID:31346092 [Fam.P1:III.2(P6)] |
105088 | M | 215638 | - | Japanese | Mucocutaneous candidiasis | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:26644313 [II.3(II.3)]; PMID:30250467 [M.II.3]; PMID:29729943 [Fam.M:II.3(M.II.3 (37))]; PMID:27418640 [P21(II.3)]; PMID:35087518 [11.1] |
105180 | M | 215662 | - | Caucasian | Mucocutaneous candidiasis | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.S:II.1(S.II.1 (47))]; PMID:27102614 [Fam.D:II.1(5)] |
105194 | M | 215665![]() |
- | Iranian | Oral candidiasis | Immunodeficiency, common variable, 8 | PMID:27888588 [Case(II.1)] |
105412 | F | 215762![]() |
- | Caucasian | Oral candidiasis | NFKB1 insufficiency | PMID:32278790 [Fam.BB:I.1(I.1)]; PMID:30063981 [Fam.1:II.2(II.2)]; PMID:150198 [Fam.BM:II.3(300)] |
105690 | F | 215840![]() |
- | Caucasian | Oral candidiasis | NFKB1 insufficiency | PMID:32278790 [Fam.BL:II.1(II.1)]; PMID:150198 [Fam.CE:II.1(417)]; PMID:36105815 [Fam.H67Y:II.1(H67Y/2)] |
105830 | M | 215887 | 5 | Polish | Mucocutaneous candidiasis | Activated p110-delta syndrome 1 | PMID:26437962 [Fam.2 Sporadic pati:2 Sporadic patient 2] |
105957 | M | 215914 | - | Caucasian | Mucocutaneous candidiasis | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.P:II.2(P.II.2 (43))] |
106017 | M | 215725 | - | Caucasian | Mucocutaneous candidiasis | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.Z:II.3(Z.II.2 (64))] |
106044 | F | 215929 | - | Caucasian | Mucocutaneous candidiasis | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.KK:II.1(KK.II.1 (85))] |
106047 | F | 215930 | 14 | Caucasian | Mucocutaneous candidiasis | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.LL:II.1(LL.II.1 (86))] |
106068 | M | 215931 | - | Caucasian | Mucocutaneous candidiasis | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.PP:II.1(PP.II.1 (96))] |
106070 | F | 215933 | - | Caucasian | Mucocutaneous candidiasis | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.SS:II.1(SS.II.1 (99))] |
106090 | M | 215946![]() |
0 | Saudi | Oral candidiasis | T-cell immunodeficiency with thymic aplasia | PMID:33464451 [P11]; PMID:37419334 [P11(27)]; PMID:31151968 [Fam.1:II.2(Patient)] |
106209 | F | 215975![]() |
70 | Finnish | Mucocutaneous candidiasis | NFKB1 insufficiency | PMID:150198 [Fam.FM:III.3(694)]; PMID:36356849 [Fam.2:III.3(F2:III:3)] |
106246 | F | 215977 | - | Caucasian | Mucocutaneous candidiasis | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.UU:III.11(UU.III.7 (111))]; PMID:29305966 [Fam.IV.2:III.2(III.2)] |
106313 | F | 215982 | - | Caucasian | Mucocutaneous candidiasis | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [P1] |
106753 | F | 216122![]() |
0 | Chinese (China) | Oral candidiasis | T-negative/B-positive SCID type 1 | PMID:31309596 [Pt(II.2)] |
106761 | F | 216124![]() |
0 | Caucasian | Oral candidiasis | T-negative/B-positive SCID type 1 | PMID:28916186 [P5]; PMID:31440277 [pt(II.1)] |
106957 | F | 216198 | - | Oral candidiasis | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:30092289 [P13] | |
107044 | M | 216283 | - | Mucocutaneous candidiasis | Activated p110-delta syndrome 1 | PMID:28983403 [P1] | |
107164 | F | 216366![]() |
2 | Sri Lankan Tamil | Oral candidiasis | Adenosine deaminase 2 deficiency | PMID:26607704 [Fam.P1:II.2(P2)] |
107175 | M | 216368 | - | Berber | Mucocutaneous candidiasis | IL-17RA deficiency | PMID:26607704 [IL17RA-case]; PMID:21350122 [Fam.A:II.5(P1)] |
107212 | F | 216374 | 0 | Arab | Oral candidiasis | Combined immunodeficiency 37 | PMID:31775018 [Patient] |
107226 | M | 216382 | 13 | North American | Oral candidiasis | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:35677041 [Pt6]; PMID:33651637 [Patient 2]; PMID:28349047 [Case] |
107247 | F | 216396 | - | Oral candidiasis | Hyper-IgE recurrent infection syndrome 1 | GRID:001501 [case] | |
107249 | F | 216398![]() |
- | Argentinian | Oral candidiasis | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:35677041 [Pt7]; PMID:29378236 [Fam.1:Patient 1] |
*Age: age reported at the first known time of manifestation; PMID: PubMed ID; GRID: GenIA reference ID (ref. not in PubMed).